Carregant...
A Preliminary Investigation of Naltrexone Augmentation of Bupropion to Stop Smoking With Less Weight Gain
Certain barriers prevent some cigarette smokers from attempting to quit, particularly the fear of post-cessation weight gain. This investigation was an open label study of naltrexone hydrochloride (25 mg/day) in combination with sustained-release (SR) bupropion hydrochloride (300 mg/day) for smoking...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2488403/ https://ncbi.nlm.nih.gov/pubmed/17587504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addbeh.2007.05.012 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|